201 related articles for article (PubMed ID: 38717734)
1. Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment.
Zhang GX; Liu TT; Ren AX; Liang WX; Yin H; Cai Y
Infection; 2024 Jun; 52(3):787-800. PubMed ID: 38717734
[TBL] [Abstract][Full Text] [Related]
2. Contezolid in complicated skin and soft tissue infection.
Kaul G; Dasgupta A; Chopra S
Drugs Today (Barc); 2022 Jul; 58(7):315-326. PubMed ID: 35851867
[TBL] [Abstract][Full Text] [Related]
3. Contezolid: First Approval.
Hoy SM
Drugs; 2021 Sep; 81(13):1587-1591. PubMed ID: 34365606
[TBL] [Abstract][Full Text] [Related]
4. A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections.
Zhao X; Huang H; Yuan H; Yuan Z; Zhang Y
J Antimicrob Chemother; 2022 May; 77(6):1762-1769. PubMed ID: 35265985
[TBL] [Abstract][Full Text] [Related]
5. Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity.
Wang W; Voss KM; Liu J; Gordeev MF
Chem Res Toxicol; 2021 May; 34(5):1348-1354. PubMed ID: 33913699
[TBL] [Abstract][Full Text] [Related]
6.
Carvalhaes CG; Duncan LR; Wang W; Sader HS
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32778552
[TBL] [Abstract][Full Text] [Related]
7. A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity
Guo Q; Xu L; Tan F; Zhang Y; Fan J; Wang X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0088921. PubMed ID: 34460305
[TBL] [Abstract][Full Text] [Related]
8. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
[TBL] [Abstract][Full Text] [Related]
9. Tedizolid: a new oxazolidinone antimicrobial.
Kisgen JJ; Mansour H; Unger NR; Childs LM
Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
[TBL] [Abstract][Full Text] [Related]
10. Oxazolidinone antimicrobials: a patent review (2012-2015).
Phillips OA; Sharaf LH
Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
[TBL] [Abstract][Full Text] [Related]
11. Linezolid--a review of the first oxazolidinone.
Norrby R
Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
13. New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.
Gordeev MF; Yuan ZY
J Med Chem; 2014 Jun; 57(11):4487-97. PubMed ID: 24694071
[TBL] [Abstract][Full Text] [Related]
14. The oxazolidinones as a new family of antimicrobial agent.
Marchese A; Schito GC
Clin Microbiol Infect; 2001; 7 Suppl 4():66-74. PubMed ID: 11688536
[TBL] [Abstract][Full Text] [Related]
15. Oxazolidinone: A promising scaffold for the development of antibacterial drugs.
Yuan S; Shen DD; Bai YR; Zhang M; Zhou T; Sun C; Zhou L; Wang SQ; Liu HM
Eur J Med Chem; 2023 Mar; 250():115239. PubMed ID: 36893700
[TBL] [Abstract][Full Text] [Related]
16. Tedizolid: a novel oxazolidinone for Gram-positive infections.
Moellering RC
Clin Infect Dis; 2014 Jan; 58 Suppl 1():S1-3. PubMed ID: 24343826
[No Abstract] [Full Text] [Related]
17. [Linezolid--new antibacterial agent of the oxazolidinone group: its importance in the control of spreading and treatment of the multidrug resistance gram-positive infections].
Budanov SV; Smirnova LB
Antibiot Khimioter; 2002; 47(7):38-42. PubMed ID: 12516195
[No Abstract] [Full Text] [Related]
18. Linezolid: an oxazolidinone antimicrobial agent.
Fung HB; Kirschenbaum HL; Ojofeitimi BO
Clin Ther; 2001 Mar; 23(3):356-91. PubMed ID: 11318073
[TBL] [Abstract][Full Text] [Related]
19. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
Mendes RE; Deshpande LM; Jones RN
Drug Resist Updat; 2014 Apr; 17(1-2):1-12. PubMed ID: 24880801
[TBL] [Abstract][Full Text] [Related]
20. Oxazolidinone antibiotics.
Diekema DJ; Jones RN
Lancet; 2001 Dec; 358(9297):1975-82. PubMed ID: 11747939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
